Safety and Efficacy of Recombinant Humanized Anti-PD-1 mAb for Patients With Locally Advanced or Metastatic Melanoma
Clinical trial NCT03013101 · UNKNOWN
Trial details
- NCT number
- NCT03013101
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-28
- Primary completion
- 2018-09-16
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.